Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Acadia Pharmaceuticals is seeking a Manager, Forecasting to provide support to the commercial organization for neuroscience or rare disease franchises. This role involves developing annual forecasts, analyzing market dynamics, and ensuring accurate product performance expectations based on historical data and insights. The position requires strong forecasting, analytical, and communication skills, as well as the ability to collaborate effectively with cross-functional teams.
Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
CFGI